Literature DB >> 27169515

Resazurin Microtiter Assay for Clarithromycin Susceptibility Testing of Clinical Isolates of Mycobacterium abscessus Group.

Natalia Fernandes Garcia de Carvalho1, Daisy Nakamura Sato1, Fernando R Pavan2, Lucilaine Ferrazoli1, Erica Chimara3.   

Abstract

BACKGROUND: Mycobacterium abscessus group has heterogeneous susceptibility pattern among species. The species is most common cause of nosocomial infections. Macrolides minimum Inhibitory concentration (MIC) determination is essential for the treatment.
METHODS: Thirty-six strains were randomly selected for performing Resazurin Microtiter Assay (REMA) for clarithromycin testing in comparison to MIC test according to Clinical and Laboratory Standards Institute (2011) recommendation. REMA has been used for detection of drug resistance in M. tuberculosis. Extended incubation was performed to detect induced resistance.
RESULTS: Thirty microliters of resazurin (0.01%) was added after visually taking MIC reading. Resistance was observed in 11.1% of M. bolletti and 4.8% of M. abscessus strains; and induced resistance was detected in 77.8% and 95.2% of M. bolletti and M. abscessus strains, respectively. All strains of M. massiliense were susceptible. The samples presented same MIC value both by visual reading and through resazurin.
CONCLUSION: The present study showed 100% concordance between both readings, with REMA providing easier to read and report results benefit. This change in reading can also reflect on the MIC determination and report, improving the test.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  Mycobacterium abscessus; clarithromycin; resazurin microtiter assay; susceptibility testing

Mesh:

Substances:

Year:  2016        PMID: 27169515      PMCID: PMC6806693          DOI: 10.1002/jcla.21933

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  27 in total

Review 1.  An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases.

Authors:  David E Griffith; Timothy Aksamit; Barbara A Brown-Elliott; Antonino Catanzaro; Charles Daley; Fred Gordin; Steven M Holland; Robert Horsburgh; Gwen Huitt; Michael F Iademarco; Michael Iseman; Kenneth Olivier; Stephen Ruoss; C Fordham von Reyn; Richard J Wallace; Kevin Winthrop
Journal:  Am J Respir Crit Care Med       Date:  2007-02-15       Impact factor: 21.405

2.  Antibiotic susceptibility pattern of rapidly growing mycobacteria.

Authors:  R Gayathri; K Lily Therese; P Deepa; S Mangai; H N Madhavan
Journal:  J Postgrad Med       Date:  2010 Apr-Jun       Impact factor: 1.476

3.  Comparative evaluation of the nitrate reduction assay, the MTT test, and the resazurin microtitre assay for drug susceptibility testing of clinical isolates of Mycobacterium tuberculosis.

Authors:  Ernesto Montoro; Dihadenys Lemus; Miguel Echemendia; Anandi Martin; Françoise Portaels; Juan Carlos Palomino
Journal:  J Antimicrob Chemother       Date:  2005-02-24       Impact factor: 5.790

4.  rpoB gene sequence-based characterization of emerging non-tuberculous mycobacteria with descriptions of Mycobacterium bolletii sp. nov., Mycobacterium phocaicum sp. nov. and Mycobacterium aubagnense sp. nov.

Authors:  Toïdi Adékambi; Pierre Berger; Didier Raoult; Michel Drancourt
Journal:  Int J Syst Evol Microbiol       Date:  2006-01       Impact factor: 2.747

5.  Resazurin microtiter assay plate: simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis.

Authors:  Juan-Carlos Palomino; Anandi Martin; Mirtha Camacho; Humberto Guerra; Jean Swings; Françoise Portaels
Journal:  Antimicrob Agents Chemother       Date:  2002-08       Impact factor: 5.191

6.  A new method for determining the minimum inhibitory concentration of essential oils.

Authors:  C M Mann; J L Markham
Journal:  J Appl Microbiol       Date:  1998-04       Impact factor: 3.772

7.  [Molecular identification of non-tuberculous mycobacteria].

Authors:  Claudia Marcela Castro; Gloria Puerto; Luz Mary García; Dora Leticia Orjuela; Claudia Llerena Polo; María Consuelo Garzón; Wellman Ribón
Journal:  Biomedica       Date:  2007-09       Impact factor: 0.935

8.  Reliable identification of mycobacterial species by PCR-restriction enzyme analysis (PRA)-hsp65 in a reference laboratory and elaboration of a sequence-based extended algorithm of PRA-hsp65 patterns.

Authors:  Erica Chimara; Lucilaine Ferrazoli; Suely Yoko Misuka Ueky; Maria Conceição Martins; Alan Mitchel Durham; Robert D Arbeit; Sylvia Cardoso Leão
Journal:  BMC Microbiol       Date:  2008-03-20       Impact factor: 3.605

9.  Biofilm development by potentially pathogenic non-pigmented rapidly growing mycobacteria.

Authors:  Jaime Esteban; Nieves Z Martín-de-Hijas; Teemu J Kinnari; Guillermo Ayala; Ricardo Fernández-Roblas; Ignacio Gadea
Journal:  BMC Microbiol       Date:  2008-10-17       Impact factor: 3.605

10.  The drug resistance profile of Mycobacterium abscessus group strains from Korea.

Authors:  Seung Heon Lee; Hee Kyung Yoo; Seol Hee Kim; Won-Jung Koh; Chang Ki Kim; Young Kil Park; Hee Jin Kim
Journal:  Ann Lab Med       Date:  2013-12-06       Impact factor: 3.464

View more
  5 in total

1.  Genetic Correlation of Antibiotic Susceptibility and Resistance Genotyping for the Mycobacterium abscessus Group.

Authors:  Huiwen Zheng; Dongxin Liu; Jie Lu; Yuanyuan Song; Shengfen Wang; Yanlin Zhao; Xin Ni
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

2.  Ethyl Acetate Fraction of Bixa orellana and Its Component Ellagic Acid Exert Antibacterial and Anti-Inflammatory Properties against Mycobacterium abscessus subsp. massiliense.

Authors:  Roberval Nascimento Moraes-Neto; Gabrielle Guedes Coutinho; Ana Caroline Santos Ataíde; Aline de Oliveira Rezende; Camila Evangelista Carnib Nascimento; Rafaela Pontes de Albuquerque; Cláudia Quintino da Rocha; Adriana Sousa Rêgo; Maria do Socorro de Sousa Cartágenes; Ana Lúcia Abreu-Silva; Igor Victor Ferreira Dos Santos; Cleydson Breno Rodrigues Dos Santos; Rosane Nassar Meireles Guerra; Rachel Melo Ribeiro; Valério Monteiro-Neto; Eduardo Martins de Sousa; Rafael Cardoso Carvalho
Journal:  Antibiotics (Basel)       Date:  2022-06-17

3.  Screening of Preselected Libraries Targeting Mycobacterium abscessus for Drug Discovery.

Authors:  Adrian Richter; Angelika Strauch; Joseph Chao; Mary Ko; Yossef Av-Gay
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

4.  Relationship between Antibiotic Susceptibility and Genotype in Mycobacterium abscessus Clinical Isolates.

Authors:  Bing Li; Shiyi Yang; Haiqing Chu; Zhemin Zhang; Weijia Liu; Liulin Luo; Wei Ma; Xiaogang Xu
Journal:  Front Microbiol       Date:  2017-09-14       Impact factor: 5.640

5.  Hydroalcoholic Extract and Ethyl Acetate Fraction of Bixa orellana Leaves Decrease the Inflammatory Response to Mycobacterium abscessus Subsp. massiliense.

Authors:  José Lima Viana; Adrielle Zagmignan; Luís Felipe Lima Lobato; Afonso Gomes Abreu; Luís Cláudio Nascimento da Silva; Joicy Cortez de Sá; Cristina de Andrade Monteiro; João Henrique Ghilardi Lago; Letícia Machado Gonçalves; Rafael Cardoso Carvalho; Lídio Gonçalves Lima Neto; Eduardo Martins de Sousa
Journal:  Evid Based Complement Alternat Med       Date:  2018-10-02       Impact factor: 2.629

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.